Which has the lower trailing P/E, MTD or WST?

MTD has the lower trailing P/E: MTD trades at 32.30 and WST at 44.93. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MTD or WST?

Over the past five years, WST grew revenue faster — MTD at a 3.54% CAGR versus WST at 5.68%.

Does MTD or WST pay a bigger dividend?

WST pays a dividend (0.25% yield), while MTD has no payments in the available dividend history.

Is MTD or WST more profitable?

MTD runs the higher net margin — MTD at 21.91% versus WST at 16.98%.

How have MTD and WST total returns compared?

Over the past 10 years, MTD delivered 13.55% and WST delivered 16.18% annualized total return. Past performance doesn't predict future results.

Mettler-Toledo International Inc. (MTD) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Mettler-Toledo International Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 12, 2026. Differences are shown without an overall score or investment verdict.

MTD

Mettler-Toledo International Inc.

$29.07B

$1,438.53HealthcareDelayed quote: Aug 12, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$24.79B

$352.29HealthcareDelayed quote: Aug 12, 2026, 4:02 PM EDT

Total return — MTD vs WST

growth of $100 · dividends reinvested · last 10y

MTD +252.3% (+13.4%/yr)WST +345.7% (+16.1%/yr)WST compounded faster over this window

MTD WST

MTD vs WST: by the numbers

•MTD is the larger company ($29.07B vs $24.79B market cap).
•MTD trades at the lower trailing earnings multiple (32.30 vs 44.93 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.91% vs 16.98% net margin).
•WST grew revenue faster over the past five years (5.68% vs 3.54% CAGR).
•WST pays a dividend (0.25% yield), while MTD has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MTD	WST
P/E ratio	32.30	44.93
Forward P/E	30.51	39.29
P/S ratio	7.01	7.53
P/B ratio	2260.20	8.38
EV / EBITDA	23.57	28.76
FCF yield	2.98%	1.74%

Profitability

Metric	MTD	WST
Gross margin	59.30%	36.77%
Operating margin	28.69%	20.64%
Net margin	21.91%	16.98%
ROE	7062.40%	18.89%
ROIC	35.46%	13.62%

Dividends

Metric	MTD	WST
Dividend yield	N/A	0.25%
Payout ratio	N/A	12.88%

Growth (annualized)

Metric	MTD	WST
Revenue CAGR (5Y)	3.54%	5.68%
EPS CAGR (5Y)	10.81%	7.85%
FCF CAGR (5Y)	2.13%	8.74%
Total return CAGR (5Y)	-0.84%	-3.38%

Frequently asked

Which has the lower trailing P/E, MTD or WST?: MTD has the lower trailing P/E: MTD trades at 32.30 and WST at 44.93. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MTD or WST?: Over the past five years, WST grew revenue faster — MTD at a 3.54% CAGR versus WST at 5.68%.
Does MTD or WST pay a bigger dividend?: WST pays a dividend (0.25% yield), while MTD has no payments in the available dividend history.
Is MTD or WST more profitable?: MTD runs the higher net margin — MTD at 21.91% versus WST at 16.98%.
How have MTD and WST total returns compared?: Over the past 10 years, MTD delivered 13.55% and WST delivered 16.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MTD analysis Full WST analysis Interactive comparison tool

Dig into the metrics

Mettler-Toledo International P/E ratio West Pharmaceutical Services P/E ratio West Pharmaceutical Services dividend yield Mettler-Toledo International ROE West Pharmaceutical Services ROE Mettler-Toledo International operating margin West Pharmaceutical Services operating margin Mettler-Toledo International revenue growth West Pharmaceutical Services revenue growth Mettler-Toledo International free cash flow West Pharmaceutical Services free cash flow

Mettler-Toledo International & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Highest ROE Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 12, 2026.